June 17, 2021
Freedom to Lead
In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies.
May 14, 2021
Pandemic-Inspired Thought Bubbles
As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share with others or keep to ourselves as we try to manage the present and anticipate the future.
March 29, 2021
Notes from the Un-Empty Nest
October 28, 2020
Reverse Mentoring with Up-and-Coming Talent
In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why then, are we not tapping into our most educated generation and exploring what millennials have to offer? (A rhetorical question, for sure.)
September 28, 2020
Commercialization Street Smarts to Inform Your S-1 Business Section
June 29, 2020
Making Virtual Workshops Work
Workshops, whether in the form of a half-day strategy session, a company-wide offsite or some other configuration, have one thing in common: They represent an opportunity for a group of people to come together in real time — to establish connections, share information, generate solutions, and achieve clear objectives. When done well, they are more than just meetings — they are highly structured, interactive, rewarding, and dare I say, fun!
May 26, 2020
Industry Leaders Speak
March 12, 2020
How to Work Remotely
I write this on the day the World Health Organization (WHO) has declared Covid-19 a pandemic. Like you, I am concerned for my family, friends, colleagues, and our country, let alone the world economy. Today’s e-conversation is focused on working remotely and how to succeed if that work approach is new to you.
July 17, 2019
Reading Recommendations from the High Cs
Summer is a wonderful time for catching up on our reading – whether business, pleasure, or something in between. This month, we sought out recommendations from leaders in our biopharma ecosystem, which is why we are calling today’s e-conversation,“Reading Recommendations from the High Cs” (C-Suite, VCs, and Commercial Leaders in Biopharma).